SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

Traders are focused on Bankrs AI-agent and crypto-trading infrastructure, citing ecosystem integrations, reported protocol revenue, and fee-linked buybacks as reasons for long-term optimism. The conversation is also driven by recent price movement, with dip-buying and accumulation alongside concerns about volatility and whether the projects fundamentals will translate into sustained demand.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff has prompted speculation about a possible reverse split or share buyback, but neither is confirmed in the discussion; traders are divided between warning of further downside and viewing the pullback as an opportunity ahead of Almontys investor day and Sangdongs production ramp.

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Q3 results are driving discussion: Schwab beat earnings expectations and reported strong asset gathering, but a slight revenue miss, slower sequential growth and softer trading revenue weighed on the shares. Traders are split between viewing the quarters underlying growth as strong and questioning whether the results justify a more positive market reaction.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVies run to new highs is drawing attention amid a broader rotation into defensive healthcare stocks as technology shares weaken, with traders highlighting the stocks breakout momentum and pipeline progress. Some see room for the rally to continue, while others warn it may be overextended and expect a pullback.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

OXY is drawing attention as traders link its recent strength and technical rebound to crude prices and Middle East supply-risk headlines, with some also pointing to Goldmans upgrade and the companys debt reduction. Sentiment is divided: bulls see support from oil-driven cash flow, while others note OXY has often lagged crude and could weaken if geopolitical tensions ease.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is drawing attention amid continued selling and uncertainty over whether REVTORPYKs commercial launch will translate into meaningful sales; traders also point to broad biotech weakness, while some are watching upcoming ESMO clinical presentations. Views are split between investors adding on the selloff and holders concerned that the decline may continue without clearer commercial traction.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

INOD is drawing attention amid a sharp pullback that traders link to broader weakness in tech and the market, with bearish chart watchers focused on a break of support and a possible gap fill. Others argue the selloff creates a buying opportunity given the companys growth prospects, while the technical outlook remains contested.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRSP is drawing attention as traders position ahead of anticipated zugo-cel and CTX310 clinical updates in November, including CTX310 data at the American Heart Association meeting. The near-term catalyst optimism is tempered by frustration over the stocks decline and long-running rangebound trading.

OpenAI

OpenAIs potential IPO is the dominant topic, with traders weighing optimism about a blockbuster listing against reports it may be pushed to 2027 amid market volatility. The debate also reflects concerns about heavy cash burn, competition and safety or legal scrutiny, while some traders see continued fundraising and business growth as supportive.

Anthropic

Anthropics anticipated mega-IPO and reported prospectus disclosures are driving discussion, with traders debating rapid revenue growth against large losses, heavy infrastructure commitments, and a potentially demanding valuation. Some see the growth and listing as compelling, while skeptics question whether the business can justify its spending and IPO expectations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A steep pullback after AEHRs AI-driven run has traders debating whether the drop is an overreaction or a reset for a richly valued stock. Bulls cite AI chip-testing demand, company guidance and follow-on orders, while skeptics question execution and await larger new-customer orders.

Implied Volatility Surging for Aehr Stock Options

Investors need to pay close attention to AEHR stock based on the movements in the options market lately.

AEHR vs. CAMT: Which Semiconductor Equipment Stock Is the Better Bet?

Aehr's AI-driven burn-in demand, record backlog and sharp fiscal 2027 growth outlook strengthen its case over Camtek despite a richer valuation.

Aehr Test Systems (AEHR) Earnings Expected to Grow: Should You Buy?

Aehr Test Systems (AEHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AEHR at 18.59X Sales: Market Loves Its AI Story, But is Love Blind?

Aehr Test Systems' 363% 2026 surge and 18.59X sales multiple reflect AI optimism, but customer concentration and execution risks leave little room for error.

Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation

Better Artificial Intelligence Stock: Aehr Test Systems vs. KLA Corporation...

Better Artificial Intelligence Stock: Aehr Test Systems vs. Super Micro Computer

Key PointsAehr Test Systems provides specialized wafer-level testing solutions for the silicon carbide and AI markets...

Can AEHR's Diversification Strengthen Its Growth Outlook?

Aehr broadens beyond SiC as AI, silicon photonics and power semiconductors fuel a more diversified growth story.

Can AEHR Turn AI Processor Tests Into Long-Term Revenue Streams?

Aehr's AI testing business gains momentum with major orders, new customer opportunities and a path toward recurring revenues.

Are Computer and Technology Stocks Lagging  Aehr Test Systems (AEHR) This Year?

Here is how Aehr Test Systems (AEHR) and Fortinet (FTNT) have performed compared to their sector so far this year.

Geospace Plunges Nearly 42% in 3 Months: How to Play the Stock?

GEOS is facing weak demand, PRM timing uncertainty and cash flow pressure, but security programs, cost cuts and seismic opportunities offer growth potential.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Why Did CRWD, S, AEHR Stocks Hit 52-Week Highs Last Week? 

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$60.60
Prev Close	$69.21
Open	$67.51
Dividend Yield	0.00%
50-Day Moving Average	$95.56
Beta	2.92
Avg. Volume	2.79M
PE Ratio	-253.45

52-Week High	$147.40
52-Week Low	$18.70
Market Capitalization	$1.98B
EPS (Annual)	-$0.2324
Price to Book	8.97
Revenue Per Employee	$362,326.09

Feed

News

Sentiment

Earnings

Fundamentals

Info

AEHR Fundamentals